Shuttle Pharma Enters Into Sponsored Research Agreement With the University of California, San Francisco to Advance PSMA Development Program

GlobeNewswireDec 19 09:00 ET

Express News | Shuttle Pharma Enters Into Sponsored Research Agreement With the University of California, San Francisco to Advance Psma Development Program

ReutersDec 19 09:00 ET

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients With Glioblastoma as UVA Cancer Center Doses Its First Patient

GlobeNewswireNov 26 09:00 ET

US Manufacturing Index Rises To 43, Highest Since 2020

Business TodayNov 16 02:13 ET

Shuttle Pharmaceuticals Holdings, Inc. Advances Phase 2 Clinical Trial for Ropidoxuridine in Glioblastoma Treatment

Quiver QuantitativeNov 13 17:49 ET

Express News | Shuttle Pharmaceuticals Q3 EPS $(1.59) Down From $(0.91) YoY

BenzingaNov 13 17:10 ET